Last updated: May 2026
By creating an account and using GeneSight, you agree to these Terms & Conditions. If you do not agree, please do not use the platform.
GeneSight is an AI-powered in-silico drug discovery platform that provides computational analysis including protein structure prediction, molecular docking, ADMET profiling, and MD simulation. Results are for research purposes only and are not medical advice.
You are responsible for maintaining the security of your account. You must provide accurate information during registration. Each account is for individual use only — sharing accounts is not permitted.
New users receive 1 free analysis upon registration. Additional analyses require a paid subscription. Subscription fees are charged in advance and are non-transferable.
GeneSight may only be used for legitimate academic, research, and commercial drug discovery purposes. You may not use the platform for illegal activities, reverse engineering, or automated scraping.
The GeneSight platform, its code, design, and branding are the intellectual property of GeneSight. Analysis results generated using your inputs belong to you.
GeneSight provides computational predictions for research use only. Results should not be used as the sole basis for clinical or pharmaceutical decisions. We make no warranties regarding accuracy of predictions.
For any questions about these terms, contact abdulrehman@genesight.cloud.